Mallano, Tatjana <br/><br/>
Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.  [electronic resource] 

 -  Annals of the rheumatic diseases  Mar 2016 
 - 586-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2014-206214  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activating Transcription Factor 3--genetics<br/>Adult<br/>Aged<br/>Animals<br/>Blotting, Western<br/>Case-Control Studies<br/>Dermis--cytology<br/>Female<br/>Fibroblasts--metabolism<br/>Fibrosis--genetics<br/>Fluorescent Antibody Technique<br/>Gene Expression Profiling<br/>Gene Expression Regulation<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Mice<br/>Mice, Knockout<br/>Middle Aged<br/>Protein Serine-Threonine Kinases<br/>Proto-Oncogene Proteins c-jun--metabolism<br/>Receptor, Transforming Growth Factor-beta Type I<br/>Receptors, Transforming Growth Factor beta<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Scleroderma, Systemic--genetics<br/>Signal Transduction--genetics<br/>Smad3 Protein--metabolism<br/>Transcription Factor AP-1--metabolism<br/>Transforming Growth Factor beta--metabolism<br/>Young Adult